Chronic binge-like alcohol consumption in adolescence causes depression-like symptoms possibly mediated by the effects of BDNF on neurogenesis  by Briones, T.L. & Woods, J.
Neuroscience 254 (2013) 324–334CHRONIC BINGE-LIKE ALCOHOL CONSUMPTION IN ADOLESCENCE
CAUSES DEPRESSION-LIKE SYMPTOMS POSSIBLY MEDIATED BY
THE EFFECTS OF BDNF ON NEUROGENESIST. L. BRIONES a* AND J. WOODS b
aDepartment of Adult Health, Wayne State University, Detroit,
MI 48202, USA
bDepartment of Biobehavioral Health Science, University of Illinois
at Chicago, Chicago, IL 60612, USAAbstract—Here we investigated whether changes in neuro-
genesis and brain-derived neurotrophic factor (BDNF)
expression are possible mechanisms involved in the
depression-like symptom during the withdrawal/abstinence
period after chronic binge-pattern alcohol consumption
given the limited number of studies addressing the link
between these factors in the adolescent brain. Forty-seven
male Sprague–Dawley rats were used in the study and the
experimental protocol started when rats were 25-days old.
Rats were assigned to either: (a) ethanol or (b) control
group. Animals in each group were further randomized to
receive either: BDNF receptor agonist or vehicle. Rats were
trained to self-administer ethanol and the binge protocol
consisted of daily 30-min experimental sessions 4 h into
the dark period for 12 days. Two days after the last drinking
session, rats were tested in the sucrose preference test to
evaluate anhedonia and the open ﬁeld test after habituation
to evaluate behavioral despair. Our data showed that: (1)
self-administration of alcohol in a binge-like pattern causes
inebriation as deﬁned by the National Institute on Alcohol
Abuse and Alcoholism and this pattern of alcohol exposure
is associated with the development of a depression-like
symptom; (2) no signiﬁcant diﬀerence in blood alcohol lev-
els between the two ethanol groups; and (3) chronic binge
drinking resulted in the development of a depressive pheno-
type, decreased survival and neuronal diﬀerentiation of neu-
ral progenitor cells in the hippocampus, and decreased
BDNF eﬀect during the withdrawal period. But the most
important ﬁnding in our study is that augmenting BDNF
actions through the use of tyrosine kinase B (TrkB, a BDNF
receptor) agonist restored neurogenesis and abolished the
alcohol-induced anhedonia and despair behaviors seen
during the withdrawal/abstinence period. Our results
suggest that BDNF might be a molecule that can be targeted
for interventions in alcoholism–depression co-incidence.
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Binge drinking in young people is on the rise in the United
States (Naimi et al., 2003), Europe (Vicki et al., 2010),
and in most developing countries throughout the world
(Courtney and Polich, 2009). Reports indicate that
alcohol consumption during adolescence is
approximately 12% in eighth graders, 22% in tenth
graders and 28% in twelfth-graders (Johnston et al.,
2004; Masten et al., 2008). Moreover, it has been
reported that more than half of 12 to 17-year-olds
consume alcohol in a binge-like fashion (Koob and Le
Moal, 1997; Crews and Nixon, 2009) making it a
common pattern of drinking among teenagers (Johnston
et al., 2004). Although some adolescents may consider
alcohol use as a ‘‘rite of passage,’’ chronic alcohol
consumption especially in a binge-like pattern is not a
benign condition that usually resolves with age. In fact,
there is increasing evidence that initiation of alcohol
consumption during adolescence increases the
probability of developing alcohol abuse and dependence
in adulthood (Grant and Dawson, 1997).
Heavy drinking during adolescence is a concern
because their brains respond diﬀerently to the eﬀects of
alcohol than the adult brain, probably because they are
still in a developmental state (Spear, 2000; Bava et al.,
2010). Indeed, clinical studies in binge drinking and
alcohol-dependent adolescents’ show hippocampal
volume reductions seen in magnetic resonance imaging
as well as functional impairments in learning and
memory processes (De Bellis et al., 2000; Nagel et al.,
2005; Medina et al., 2007; Schulteis et al., 2008;
Schweinsburg et al., 2010). Several reports consistently
show that the adolescent limbic system is susceptible
to alcohol’s memory-impairing and mood-alteringC BY license.
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2005). The drive for excessive alcohol consumption to
neurotoxic levels seen in adolescents during binge
drinking may be because they are resistant to the
motor-impairing and sedative eﬀects of alcohol but
sensitive to its rewarding and reinforcing properties
(Doremus et al., 2010), when compared to adults.
Clinical reports show that young people between 16 to
19 years of age who engage in alcohol use in a binge-
like pattern are six times more likely to experience
depression compared to their non-drinking counterparts
(Deykin et al., 1987; Boden and Fergusson, 2011).
Taken together, these reports suggest that structural
changes in the limbic area of the brain may underlie the
cognitive and aﬀective impairments seen as a
consequence of chronic alcohol use.
A key limbic structure particularly susceptible to
alcohol-related damage is the hippocampal formation
(De Bellis et al., 2000; Nagel et al., 2005; Boden and
Fergusson, 2011). Many believe that the structure and
function of the hippocampus rely upon the neural
progenitor cells (NPCs) present in the subgranular zone
of the dentate gyrus and its role in constitutive
neurogenesis (Kempermann et al., 2004; Imayoshi
et al., 2008). Accumulating evidence indicates that
hippocampal neurogenesis plays a role in learning and
memory as well as depression (reviewed in Gould et al.,
1999) suggesting the possibility that alcohol eﬀects on
neurogenesis may be a contributing factor in the
cognitive and aﬀective impairments seen in alcohol use.
Structural changes that occur in the brain during
alcohol consumption and withdrawal are accompanied
by several molecular mechanisms. Brain-derived
neurotrophic factor (BDNF) is a pivotal molecule
identiﬁed as a major regulator of structural changes in
the brain in response to alcohol use. For example,
BDNF is implicated in neurogenesis (Lee and Son,
2009; Shen and Cowan, 2010), depression (Duman and
Monteggia, 2006; Neto et al., 2011), and the synaptic
changes seen in the adult brain associated with drug
addiction (Pandey et al., 2006). In the this study we
examined whether changes in neurogenesis and BDNF
expression are possible mechanisms involved in the
depression-like symptom during the withdrawal/
abstinence period induced by chronic binge-pattern
alcohol consumption given the limited number of studies
addressing the link between these factors in the
adolescent brain.EXPERIMENTAL PROCEDURES
Animal model
A total of forty-seven male Sprague–Dawley rats were
used in the study, housed in pairs upon arrival from the
breeder, and acclimated to their new environment
for 1 week before starting the study to provide them the
advantage of dealing with the potential stress related
to the experimental manipulations. The experimental
protocol (Fig. 1) started when rats were 25 days old
to closely parallel the human adolescent population.
Rats were randomly assigned to either: (a) ethanol +tyrosine kinase B (TrkB) agonist (n= 12), (b) ethanol
group + vehicle (n= 12), or (c) control + TrkB agonist
(n= 12), or (d) control + vehicle (n= 11). Rats in the
ethanol+ TrkB agonist (ETOH+ TrkB) group were
trained to self-administer sweetened ethanol and given
the TrkB receptor agonist intraperitoneally (i.p.). Rats in
the ethanol+ vehicle (ETOH+ vehicle) group were
trained to self-administer sweetened ethanol and given
equal volume of vehicle solution i.p. Animals in the
control (CON) groups received water but the TrkB group
received the receptor agonist i.p. while the vehicle group
received equal volume of vehicle injections. Animals had
free access to food and water and were handled daily
throughout the study. The animal housing room was
maintained at 24 C± 1.5 C, room humidity controlled
and a 14:10-h light:dark cycle was maintained. All
animals were housed in the same room so that
temperature, humidity, and lighting conditions were
similar for all groups. All experimental protocols were
approved by the Institutional Animal Care and Use
Committee and were in accordance with the National
Institutes of Health guidelines.Ethanol oral self-administration
Rats were trained to self-administer ethanol versus water
in a two-bottle choice home cage situation. Training
consisted of two daily sessions starting 4 h into the dark
cycle where food was removed and two-bottles were
placed on the cage lid: one containing water and the
other sweetened ethanol. During training, rats remained
in their home cage and were allowed to drink from the
2-bottle system throughout the entire dark cycle.
Sweetened ethanol (10% w/v) was prepared with 95%
ethyl alcohol and tap water + 3% glucose and 0.125%
saccharin (Sigma Aldrich, St. Louis, MO, USA). All rats
acquired the behavior after the training sessions and the
experimental period started the following day. During the
experimental period, food was removed and bottles with
ethanol and water were attached to the cage lid with
stainless steel springs to reduce spilling starting 4 h into
the dark cycle and rats were allowed to drink for 30 min.
The position of the bottles was alternated daily to avoid
possible side preference. All bottles were weighed
immediately before and after the 30-min drinking
sessions. Diﬀerences in bottle weights were converted
to volume intakes by accounting for the ethanol solution
density (weight in grams/0.9868). The binge drinking
protocol was conducted for 12 consecutive days. Level
of intoxication was assessed using the behavioral
intoxication scale (Knapp and Crews, 1999): 0 – normal;
1 – hypoactive; 2 – presence of ataxia; 3 – ataxia
accompanied by delayed righting reﬂex; 4 – loss of
righting reﬂex; 5 – loss of eye blink.Drug administration
The selective BDNF TrkB receptor agonist
7,8-dihydroﬂavone (7,8-DHF) was given i.p. at 5 mg/kg.
The drug was purchased from TCI America (Portland,
OR, USA) and dissolved in dimethyl sulfoxide (DMSO)
and diluted with a ﬁnal DMSO concentration of 0.02%.
Fig. 1. Study timeline. Legend: PD – postnatal day, ETOH – alcohol.
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concentration and equal volume of injection was given.
Vehicle or 7,8-DHF was given daily 30 min prior to the
12-day drinking sessions. The TrkB receptor agonist, 7,8-
DHF has been shown to cross the blood–brain barrier
and induces dimerization and autophosphorylation of the
tyrosine receptor leading to activation of its downstream
signaling (Jang et al., 2010). Moreover, 7,8-DHF
presents better pharmacokinetic properties than BDNF
and higher TrkB binding aﬃnity, thus it mimics BDNF
ligand function.
Bromodeoxyuridine (BrdU) injections
The thymidine analog BrdU (Chemicon, Temecula, CA,
USA) was used to label proliferating cells. BrdU is
incorporated into the genetic materials on mitotic
division within 2 h after injection, after which it can be
detected immunohistochemically in the daughter cells
(Kuhn et al., 1996). BrdU was dissolved in 0.9% sterile
NaCl and ﬁltered at 22 lm. The resulting solution was
injected at 75 mg/kg i.p. BrdU injections were given for
three consecutive days starting on postnatal day 25
(start of experimental protocol).
Testing for ‘depressive phenotype’
To assess depression-like symptoms, the sucrose
preference and open ﬁeld tests were conducted 2 days
after the last drinking session. For the sucrose
preference test, rats were acclimated to a two-bottle
choice of drinking water and 1% sucrose solution for
2 days followed by 2 days of testing. On the day of
testing, two pre-weighted bottles of: 5% sucrose solution
and tap water were presented. To prevent possible
eﬀects of side preference in drinking behavior, the
position of the bottles was switched after 24 h of testing.
No food or water deprivation was applied before or
during the test. Liquid consumption from each bottle
corrected by body weight was used to calculate sucrose
solution intake, water intake and total consumption
by the end of the 48-h period. Sucrose preference was
calculated using the following equation: sucrose
preference (%) = sucrose intake/(sucrose intake +
water intake)  100.
The open ﬁeld testwas conducted the day after sucrose
preference test between 10 a.m. to 12 p.m. The test
was conducted using a black Plexiglas square box
(100 100 50 cm). Before testing, rats were habituatedto the testing apparatus by placing them individually in the
box for 20 min 2 days then tested the day after. The
box was cleaned with 70% ethanol after each rat.
The box was divided into two areas: peripheral area and
center area (60  60 cm). During testing, rats were
placed in the peripheral area then allowed to freely
explore for 5 min. Activity in the open ﬁeld was recorded
with a camera connected to a computerized videotracking
system (EthoVision XT, v8.5; Noldus Technology,
Leesburg, VA, USA), which provided measures of
immobility time, horizontal movement (distance covered
during locomotion), and number of entries in the center
area.Blood alcohol concentration (BAC)
Blood samples were collected from the saphenous vein
60 min following the 30-min binge session. Samples
(0.5 ml) were collected every other day then
centrifuged for 5 min at 1800g to separate the plasma
and then stored at 20 C until time of assay. Serum
BAC levels were determined using the Blood Ethanol
Analyzer Model GL5 (Analox Instruments, Lunenburg,
MA, USA) calibrated with a 300 mg/dL external
standard. Measurements were performed in triplicate,
averaged and used as one individual data point.Tissue preparation
At the end of the experimental protocol, all rats were
euthanized. Euthanasia involved use of CO2 inhalation
followed by decapitation once rats became
unresponsive. At the time of sacriﬁce, hippocampal
tissues used for Western blot and enzyme-linked
immunosorbent assay (ELISA) were dissected and
placed in liquid nitrogen until processed. Brains used for
immunohistochemistry were placed in a ﬁxative solution
(4% paraformaldehyde, pH 7.4) overnight then
cryoprotected with 30% sucrose in 0.1 M phosphate-
buﬀered saline solution containing 25% ethylene glycol
and stored at 20 C until they were sectioned. Coronal
sections were obtained throughout the entire
hippocampal formation using a cryostat at 20-lm
thickness.Immunohistochemistry
The free-ﬂoating section method was used to examine
neurogenesis in the dentate gyrus (Briones et al., 2005;
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nuclei, DNA was denatured to expose the antigen before
incubation in anti-BrdU primary antibody. Brieﬂy, free-
ﬂoating sections were pretreated in 50% formamide/
50% 2 saline-sodium citrate buﬀer (SSC) at 65 C for
2 h, rinsed in 2 SSC, and then incubated in 2 N HCl at
37 C for 30 min. Tissues were rinsed in borate buﬀer
(pH 8.5) for 15 min and placed in 0.6% H2O2 in Tris-
buﬀered saline (TBS) for 30 min to block endogenous
peroxidase, followed by several rinses in TBS (pH 7.5).
Tissues were placed in TBS/0.1% Triton X-100/3%
donkey serum (TBS-TS) for 1 h followed by incubation
with anti-BrdU primary antibodies at a concentration of
1:400 (monoclonal mouse; Boehringer Mannheim;
Indianapolis, IN, USA) in TBS-TS overnight at 4 C. The
following day, the primary antibody was detected using
biotinylated immunoglobulin G (IgG) donkey anti-mouse
secondary antibodies (Vector Laboratories; Burlingame,
CA, USA) at a concentration of 1:200 for 2 h. Tissues
were rinsed in TBS and incubated in avidin–biotin
complex (ABC kit; Vector Laboratories) for 1 h at room
temperature. Immunoreactions were visualized by
treatment of section with hydrogen peroxide and
3,30-diaminobenzidine tetrahydrochloride in Tris buﬀer
(pH 7.3). After thorough rinsing, the tissue sections
were mounted on gelatin-coated slides and dried, and
coverslips were applied. To minimize intergroup and
interbrain staining variability and to ensure
reproducibility of results, tissues from all experimental
groups were run simultaneously and under identical
conditions.
To determine survival and diﬀerentiation of newly
formed cells, the total number of BrdU-positive cells in
the granule cell layer and its corresponding sample
volume were determined in eight coronal sections,
240 lm apart, using the optical dissector method
(StereoInvestigator, MicroBrightﬁeld, Colchester, VT,
USA). Brieﬂy, each section was examined at a
magniﬁcation of 40, and an unbiased counting frame
was positioned randomly across the dentate gyrus area.
The number of labeled cells was related to the number
of sections counted multiplied by the reference volume
to provide an unbiased estimation of the total number of
BrdU-positive cells as previously described (Briones
et al., 2005; Briones and Woods, 2011). To determine
phenotype of surviving newly formed cells, the antibody
anti-doublecortin (DCX) (1:400; Santa Cruz
Biotechnology, CA, USA), marker for immature neurons,
was used. DCX immunoreactivity was quantiﬁed by
optical densitometry with an image analysis software
(Bioquant Image Analysis, R&M Biometric, Nashville,
TN, USA). Densitometry measurements were divided by
the area of the tissue section and expressed as pixels/
mm2.
ELISA
To detect BDNF level, ELISA was carried out using the
BDNF Emax ImmunoAssay System kit (Promega,
Madison, WI, USA) according to manufacturers
speciﬁcations. Frozen hippocampal tissues (0.2 g) were
homogenized with a glass homogenizer in extractionbuﬀer (pH 7.5) containing Tris–acetate 20 mM, NaCl
150 mM, 1 mM EDTA, 1 mM Na pyrophosphate,
100 mM phenylmethylsulfonyl ﬂuoride (PMSF), leupeptin
1 mg/ml and centrifuged at 12,000g for 20 min at 4 C.
The supernatant was collected and total protein was
determined by bicinchoninic acid (BCA) protein assay
reagent kit (Pierce, Milwaukee, WI, USA). Brieﬂy,
96-well plates precoated with monoclonal antibody
speciﬁc for BDNF were incubated at 4 C overnight on
an orbital plate shaker (250 rpm) then washed 2 with
wash buﬀer (pH 7.6) containing Tris HCl 20 mM, NaCl
150 mM, and 0.05% Tween. The blocking buﬀer (200 ll)
provided by the manufacturer was then added to the
well together with the sample (100 ll) then incubated at
room temperature for 1 h followed by several washes.
After washing, the immobilized antigen was incubated
with monoclonal anti-BDNF overnight at 4 C. The
plates were washed again and then incubated with anti-
mouse IgG horseradish peroxidase conjugate for 2 h at
room temperature. Tetramethyl benzidine/peroxidase
substrate solution was added to the wells after washing
to produce the color reaction then incubated for 15 min.
Color reaction was stopped with 1 N HCl (100 ll) and
reaction was read in a microplate reader (Bio-Tek,
Winooski, VT, USA) at a wavelength of 450 nm (650-nm
reference wavelength). BDNF concentration was
determined from the regression line for the BDNF
standard corrected for the total amount of protein in the
sample and assay sensitivity ranged from 7.8 to 500
pg/ml. Assay was performed in triplicate and
measurements were averaged and used as one
individual data point for statistical analysis.
Western blot
To detect levels of TrkB and phosphorylated TrkB
(p-TrkB), 0.5 g of frozen hippocampal tissues was
homogenized and centrifuged at 25,000g for 20 min as
previously described (Briones et al., 2006, 2009).
Aliquots from the supernatant were removed for protein
determination. Protein concentration in samples was
determined using the BCA–Protein assay (Pierce,
Rockford, IL). The primary antibodies used are: (1) anti-
TrkB (1:750, BD Biosciences, San Jose, CA) and (2)
anti-phosphoTrkB (1:1000, Santa Cruz Biotechnology,
CA). For Western blot analyses, equal amounts of
protein (40 lg) from each rat were loaded and
separated by SDS–PAGE gel electrophoresis in 8–16%
acrylamide gradient gels. The protein bands were
transferred electrophoretically to nitrocellulose
membranes (Amersham, Piscataway, NJ) stained with
0.5% Ponceau Red to visualize total proteins, then
destained. Non-speciﬁc binding sites were blocked then
nitrocellulose membranes were incubated overnight at
4 C with gentle agitation in the primary antibody.
The secondary antibodies used are horseradish
peroxidase-conjugated immunoglobulin (Sigma, St. Louis,
MO) and the Super Signal chemiluminescense substrate
kit (Pierce, Rockford, IL) was used to visualize
immunoreactive bands. After visualization, the membranes
were then stained with Amido-Black to qualitatively verify
protein loading. Samples were analyzed in quadruplicate
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individual data point for statistical analysis.
Quantiﬁcation of diﬀerences in protein bands between
samples was done using densitometric analysis (Scion
Image Beta 4.0.2; Frederick, MD, USA). The internal
control b-actin was used to standardize experimental
values in densitometric analysis.Statistical analysis
The SAS general linear model (SAS Institute, North
Carolina, USA) procedures for analysis of variance
(ANOVA) were used to examine eﬀects of experimental
conditions (ethanol vs. saline groups; TrkB agonist vs.
vehicle) on neurogenesis, BDNF expression, sucrose
preference test, and open-ﬁeld test. Repeated measures
ANOVA were used to examine eﬀects of chronic binge-
pattern alcohol exposure on BAC. All error bars
represent ± standard error of the mean (SEM) of the
sample size used in the study.RESULTS
Binge alcohol consumption causes intoxication
BAC was determined from the samples analyzed every
other day and repeated measures analysis showed no
signiﬁcant diﬀerence in levels over the course of the
ethanol exposure paradigm (Fig. 2A). Also, no
signiﬁcant diﬀerence was seen in alcohol consumption
between the ETOH+ vehicle and ETOH+ TrkB groups
(Fig. 2B). On average, rats in the ethanol groups
consumed greater than 0.75 g/kg alcohol during the
30-min drinking session and produced BAC P0.08 g%,
which reﬂects the deﬁned BAC threshold for bingeFig. 2. BAC level. Alcohol was administered in a binge-like pattern for 12 day
intake (B) was not signiﬁcantly diﬀerent between the ETOH groups; and the in
the scatterplot illustrating a single day of drinking session (C). Legend: BACdrinking by the National Institute of Alcohol Abuse and
Alcoholism (NIAAA, 2004). The BAC and ETOH intake
values observed were highly correlated (Fig. 2C) and
consistent throughout the 12-day period suggesting that
the alcohol-treated groups were intoxicated to the same
degree. Furthermore, the intoxication behavior score
between the ethanol groups was not signiﬁcantly
diﬀerent (Table 1) across the 12-day drinking period.
Binge ETOH consumption causes depression-like
symptoms
To evaluate if binge alcohol exposure can cause
depression-like symptoms and whether increasing
BDNF signaling can attenuate the eﬀects of alcohol in
this aﬀective behavior, we performed the sucrose
preference and open ﬁeld tests (Fig. 3). The sucrose
preference test was given 48 h after the last alcohol
intake to evaluate anhedonia, a major feature of
depressive disorder. We found a signiﬁcant main eﬀect
of alcohol in that rats in the ETOH+ vehicle group
drank signiﬁcantly less sucrose solution in comparison
to the control groups and ETOH+ TrkB group
(F(3,43) = 6.81, p= 0.031). Rats in the ETOH+ vehicle
group consumed approximately 28% and 26% less of
the sucrose solution when compared to the control
groups and the ETOH+ TrkB groups respectively.
Posthoc comparisons showed no signiﬁcant diﬀerence
in sucrose consumption between the ETOH+ TrkB and
control groups. Meanwhile, no signiﬁcant diﬀerence was
seen in the total liquid consumption between the groups
(Table 1).
The open ﬁeld is a widely used test for depressive-like
symptoms (Che et al., 2013) because it provides
information on ‘despair’ behavior (immobility), actives and BAC was determined every other day. Both BAC (A) and alcohol
creased BAC seen to correspond with alcohol consumption as seen in
– blood alcohol concentration.
Table 1. Intoxication score and liquid intake. Intoxication scores taken
during the binge drinking sessions were averaged. As well, liquid intake
during the 2-day sucrose preference test was averaged. Both alcohol
groups showed nearly identical intoxication scores. Similarly, liquid
intake during the sucrose preference test showed no signiﬁcant group
diﬀerences
Group Average intoxication
score
Total liquid intake
(%)
ETOH+ vehicle 2.2 ± 0.23 81.96 ± 9.2
ETOH+ TrkB 2.0 ± 0.30 77.43 ± 8.01
CON+ vehicle 0 79.23 ± 8.31
CON+ TrkB 0 80.11 ± 7.32
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(number of entries in the center area). Our results
showed that the ETOH+ vehicle group had signiﬁcantly
longer immobility time (F(3,43) = 6.01, p= 0.030)
and decreased horizontal movements (F(3,43) = 7.02,
p= 0.029) in the open ﬁeld compared to the
ETOH+ TrkB and control groups. Post hoc
comparisons showed no signiﬁcant diﬀerences in
behaviors in the open ﬁeld between the ETOH+ TrkB
and control groups. No signiﬁcant group diﬀerences
were seen in the number of entries in the center area.
Together, these results suggest that the depressive
phenotype (i.e. anhedonia and despair) is manifested
during the withdrawal/abstinence period from binge
ethanol exposure but augmenting BDNF actions during
ethanol consumption can abolish this negative eﬀect of
alcohol on aﬀective behavior.Binge alcohol consumption decreases survival and
neuronal diﬀerentiation of NPCs
Since BrdU was injected at the onset of the binge drinking
protocol, we were able to assess the number of dividing
cells that survived until the brains were removed by
quantifying the total number of BrdU-labeled cells in the
dentate gyrus of the hippocampal region. We found that
BrdU-positive cells appear as punctate staining and
most labeled cells were in clusters present in both
blades of the dentate gyrus. A signiﬁcant main eﬀect
of alcohol (F(3,43) = 8.03, p= 0.024) was seen in that
the number of BrdU-positive cells per hippocampal
volume in the ETOH+ vehicle group decreased by
approximately 26% and 31% in comparison to theFig. 3. Test for depressive-like symptoms. Signiﬁcant decreased in hedonic re
(open ﬁeld test) in the ETOH+ vehicle group compared to the ETOH+ Trk
agonist inhibited the alcohol-induced depression phenotype. ⁄p< 0.05.ETOH+ TrkB and control group that received vehicle,
respectively (Fig. 4A). A signiﬁcant main eﬀect of
7,8-DHF (F(3,43) = 9.35, p= 0.021) was also seen in
that overall, the control group that received the TrkB
agonist showed the highest number of BrdU-labeled
cells. These results suggest that ETOH and BDNF have
detrimental and enhancing eﬀects, respectively, on cell
proliferation.
We also examined the phenotype of the BrdU-labeled
cells by using the marker DCX for quantiﬁcation of
immature neurons. DCX can provide information on the
number of NPCs that proliferated, survived,
diﬀerentiated into neurons, and begun to develop
neurites (Couillard-Despres et al., 2005). We found
signiﬁcant main eﬀect of alcohol (F(3,43) = 10.06,
p= 0.020) in that the density of DCX immunoreactivity
was lower in the ETOH+ vehicle group relative to the
ETOH+ TrkB and control groups (Fig. 4B). Meanwhile,
no signiﬁcant diﬀerence was seen in DCX
immunoreactivity between the ethanol + TrkB and
control group that received vehicle. A main eﬀect of 7,8-
DHF (F(3,43) = 10.24, p= 0.018) was also seen in that
the density of DCX immunoreactivity was signiﬁcantly
increased overall in the control group that received the
TrkB agonist. Collectively, these results suggest that
neurotoxic substances such as alcohol can inhibit
survival and diﬀerentiation of proliferating NPCs;
however, enhancing BDNF actions increased
neurogenesis and prevented the toxic eﬀects of alcohol.Binge alcohol aﬀects BDNF function
To gain insight into a possible mechanism that mediates
alcohol eﬀects on neurogenesis and depression-like
symptoms we examined BDNF function in the
hippocampus. Our results showed decreased BDNF
levels in the ETOH+ vehicle group when compared to
the control groups and ETOH+ TrkB group (F(3,43) =
7.49, p= 0.033). BDNF level in the ETOH+ vehicle
group is 30% and 21% lower when compared to the
ETOH+ TrkB and control group that received vehicle,
respectively (Fig 5A). Post hoc comparisons showed no
signiﬁcant diﬀerence in BDNF expression between the
ETOH+ TrkB and control group that received vehicle.
Comparison of the control groups showed signiﬁcantly
increased BDNF level in animals that received the TrkB
agonist.sponse (sucrose preference test) and increased in behavioral despair
B and control groups. Augmenting BDNF signaling by giving the TrkB
Fig. 4. (A) BrdU labeling. Upper panel: Representative photomicrographs of BrdU staining scattered along both blades of the dentate gyrus. Lower
panel: Bar graph shows signiﬁcantly decreased survival of proliferating NPCs in the ETOH+ vehicle group compared to the ETOH+ TrkB and
control rats. Overall, control rats that received the TrkB agonist showed the highest number of BrdU-labeled cells. These results suggest the role of
BDNF in neuronal plasticity and its neuroprotective eﬀects against the detrimental eﬀects of alcohol. (B) DCX labeling. Upper panel: Representative
photomicrographs of DCX staining in the dentate gyrus. Lower panel: Bar graph shows signiﬁcantly decreased DCX immunoreactivity in the
ETOH+ vehicle group compared to the ETOH+ TrkB and control rats. Control rats given the TrkB agonist showed the highest density of DCX
staining. These results suggest the enhancing eﬀects of BDNF signaling on the surviving newly formed cells to diﬀerentiate into neuronal phenotype.
⁄p< 0.05; ⁄⁄p< 0.01 (post hoc comparisons). Scale bar = 200 lm (left) and 100 lm (right).
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receptor TrkB, showed no signiﬁcant groups diﬀerences
in total TrkB level (Fig. 5B). However, analysis of levels
of phosphorylated TrkB showed that expression in the
ETOH+ vehicle group is 30% and 32% lower
compared to the ETOH+ TrkB and control group that
received vehicle, respectively (Fig. 5C). Post hoc
comparisons revealed that levels of phosphorylated
TrkB in the ETOH+ TrkB and the control group that
received vehicle are not signiﬁcantly diﬀerent. However,
comparison of the control groups showed signiﬁcantly
increased phosphorylated TrkB level in animals that
received the agonist. These results suggest that chronic
ethanol exposure during adolescence caused a
reduction in the expression of BDNF and its ability to
activate the TrkB receptor. Giving TrkB agonist not only
reversed alcohol eﬀects on receptor activation but also
increased BDNF expression.DISCUSSION
The primary objective of the study is to empirically test the
possible mechanisms that underlie the depression-like
symptom during the withdrawal/abstinence period afterchronic binge alcohol drinking in adolescence. The
impetus for the study are the epidemiological reports on
the increased incidence of alcohol consumption in a
binge-like pattern among adolescents (Naimi et al.,
2003; Johnston et al., 2004; Masten et al., 2008;
Courtney and Polich, 2009; Vicki et al., 2010), and the
rise in suicide rates in this age group prompted by
depression (Deykin et al., 1987; Boden and Fergusson,
2011) suggesting a link between these two factors. The
key ﬁndings that emerged in this work are that: (1)
binge-like drinking causes inebriation as deﬁned by the
NIAAA and this pattern of alcohol exposure is
associated with the development of a depression-like
symptom, and (2) the possible mechanisms involved in
the development of a depression-like symptom during the
withdrawal/abstinence period after chronic binge alcohol
exposure are decreased survival and diﬀerentiation of
proliferating cells possibly mediated by reductions in
hippocampal BDNF function.
In our study, rats exposed to alcohol in a binge-pattern
reached BAC 0.08 g% during acute consumption, which
is considered to be an intoxicated state (NIAAA, 2004).
Alcohol impairs the functioning of a variety of behavioral
domains including memory and judgment [reviewed in
Fig. 5. BDNF action. (A) ELISA results show signiﬁcant decrease in BDNF protein in the ETOH+ vehicle group in relation to the ETOH+ TrkB
and control groups. Control rats that received the TrkB agonist showed the highest levels of BDNF. No signiﬁcant group diﬀerences were seen in
total TrkB levels (B) but signiﬁcant decreased in phosphorylated TrkB expression is evident in the ETOH+ vehicle group compared to the
ETOH+ TrkB and control groups (C). The highest level of phosphorylated TrkB was seen in the control group that received 7,8-DHF. These results
suggest that giving the TrkB agonist abolished the eﬀects of alcohol on BDNF action. Representative Western blots are shown in the lower panel,
right. ⁄p< 0.05 and ⁄⁄p< 0.01 (post hoc comparisons).
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and Vogel-Sprott, 2002). Additionally, alcohol can also
cause aﬀective impairment such as anxiety (Pandey
et al., 2006, 2008) and depression (Caldwell et al.,
2008; Hauser et al., 2011). In the present study we
examined the eﬀects of chronic alcohol exposure on a
depression-like symptom because of the dearth of
information on this topic in the adolescent brain even
though increasing evidence shows that incidence of
depression is higher in adolescents compared to adults
(Rao, 2006). Our data show decreased hedonic and
despair behaviors in rats exposed to alcohol alone
(ETOH+ vehicle) during the withdrawal period where
they demonstrate a signiﬁcantly diminished preference
for sweet substances in the sucrose preference test and
increased immobility time, as well as decreased
locomotor activity in the open ﬁeld test in comparison to
the ETOH+ TrkB and control groups. The anhedonia
and despair seen in the ETOH+ vehicle rats in this
study is consistent with those reported by others in adult
rats (Hauser et al., 2011) and mice (Stevenson et al.,
2009) given alcohol daily for several days and also in
adult mice prenatally exposed to alcohol that
demonstrate increased learned helplessness and
immobility in the forced swimming test (Caldwell et al.,
2008). Our results are also in line with epidemiological
data that report chronic alcohol misuse and alcohol
dependence in adults are associated with rates of major
depressive disorder ranging from 30% to 50% (Regier
et al., 1990; Sullivan et al., 2005). Clinical studies show
that the development of depressive and addictivedisorders among adolescents are considered to be even
higher than that observed in adults (Regier et al., 1990;
Rohde et al., 1991) with the highest incidence seen
between 15 and 19 years of age (Sullivan et al., 2005).
The development of depression during the withdrawal/
abstinence period following chronic alcohol use may be
attributed to the cyclic pattern of euphoria after alcohol
consumption followed by the dysphoric mood that
accompanies the withdrawal period. Thus, chronic binge
drinking may increase the risk for the development of
long-term aﬀective impairment since it produces
repeated euphoria and dysphoria.
Determining the neural mechanisms that may be
involved in mediating depression in alcoholism is a
crucial step in understanding these comorbid disorders.
One of the mechanisms we examined in this study is
neurogenesis and we demonstrate that rats exposed to
alcohol alone (ETOH+ vehicle) in a binge-like pattern
for 12 days show signiﬁcantly decreased number of
BrdU-labeled cells and DCX immunoreactivity in the
dentate gyrus when compared to the ETOH+ TrkB and
control groups during the withdrawal period. These data
suggest that alcohol can inhibit the survival and
neuronal diﬀerentiation of proliferating NPCs. Our
results parallel the ﬁndings of others that report
inhibition of NPC proliferation in the dentate gyrus
following chronic alcohol exposure in adolescent rats
(He et al., 2005; McClain et al., 2011) and mice
(Stevenson et al., 2009), as well as adult rats when
exposed to alcohol prenatally (Hamilton et al., 2011). It
is possible that imaging reports of smaller hippocampal
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(De Bellis et al., 2000; Nagel et al., 2005) and on adults
diagnosed with depression (Sheline et al., 2003;
Sullivan et al., 2005) may be explained by decreased
cell proliferation demonstrated in these studies.
However, our results are in contrast with a previous
study that reported increased cell proliferation during the
withdrawal period (Nixon and Crews, 2004). The
conﬂicting ﬁndings may be due to the mode of alcohol
administration and the use of a drug to reduce
withdrawal severity. Namely, our study used the alcohol
self-administration paradigm whereas the other study
used the gastric gavage administration method and
withheld food during the binge paradigm possibly
leading to increased withdrawal severity. Indeed, the
other study administered diazepam to control the
severity of alcohol withdrawal; thus, the anti-depressive
properties of diazepam in combination with greater
withdrawal severity most likely led to withdrawal-induced
increased cell proliferation as reported in the other study.
How alcohol aﬀects neurogenesis is still poorly
understood but it is possible that it: (1) alters the cell
cycle (Morris et al., 2010) and interferes with
proliferation, and (2) decreases BDNF action that
promotes cell survival and diﬀerentiation as evidenced
in our data on the ETOH+ TrkB group. The importance
of BDNF in neurogenesis is evident from our results that
show administration of the TrkB agonist in the saline
control group increased cell proliferation and neuronal
diﬀerentiation in the dentate gyrus. These ﬁndings are
consistent with previous reports that demonstrate the
role of BDNF/TrkB in brain plasticity. That is, BDNF/
TrkB promotes the survival and diﬀerentiation of NPCs,
as well as increases the branching of axons and
dendrites and stabilizing synaptic contacts of existing
neurites (reviewed in Neto et al., 2011). What is not
clear from our results however, but clearly plausible is
whether the protection conferred by BDNF on the
survival of proliferating NPCs may have been
augmented by the reported compensatory burst in cell
proliferation during the alcohol withdrawal period (Nixon
and Crews, 2004). This issue can be addressed in
future studies that make clear the time course of
changes in various phases of neurogenesis during
alcohol withdrawal following binge drinking.
Our study also show signiﬁcantly decreased BDNF
protein levels as well as reductions in phosphorylated
TrkB expression in the hippocampus of rats given
alcohol alone (ETOH+ vehicle) in comparison to the
ETOH+ TrkB and control groups and this reduction is
most likely due to decreased BDNF signaling. Our
results are in line with other experimental studies that
show signiﬁcantly lower hippocampal BDNF levels in
adult rats that demonstrate anhedonia following alcohol
exposure, and adult mice that demonstrate learned
helplessness when exposed to alcohol prenatally
(Caldwell et al., 2008; Hauser et al., 2011). BDNF may
be an important molecule in the hippocampus to
mediate some of the functional consequences of
ethanol exposure such as depression. Indeed, clinical
studies show signiﬁcant reductions in peripheral BDNFlevel in patients with alcohol dependence diagnosed
with major depression (reviewed in Duman and
Monteggia, 2006). Collectively these data suggest a role
for hippocampal BDNF eﬀects in the depression-like
symptom induced by alcohol.
Our results on BDNF expression however, are in
contrast to those who report increased BDNF
expression in the hippocampus of adult rats following
12 h of alcohol withdrawal (Tapia-Arancibia et al., 2001).
Some possible explanations for the diﬀerence in ﬁndings
may be the alcohol paradigm used, age of the brain
examined, and timing of measurement during the
withdrawal period. Namely, our study used the chronic
binge-pattern alcohol paradigm and we examined the
adolescent brain 7 days after the last alcohol
consumption. In contrast, the other study used the
alcohol vapor paradigm and examined the adult brain
12 h after the last alcohol exposure. Thus, it is possible
that consuming large quantities of alcohol at a time such
as those seen in the vapor paradigm, is more damaging
to the developing adolescent brain. Similarly, our results
are in conﬂict with reports of increased serum BDNF in
adult alcoholics a week after their last alcohol
consumption (Huang et al., 2008; Costa et al., 2011).
An explanation for the diﬀerence in results between our
study and the clinical reports of decreased serum BDNF
in alcoholic patients weeks after withdrawal is the
measurement used. That is, the clinical reports
measured serum BDNF level while our study examined
expression in hippocampal tissues. Peripheral levels of
BDNF reﬂected in serum will likely diﬀer from central
expression.
Our results also diﬀer from a recent study that reports
no diﬀerence in BDNF expression in the adolescent brain
between the ethanol and control group following a 4-day
binge (McClain et al., 2013). A possible reason for these
conﬂicting ﬁndings is that we measured BDNF
expression after completion of behavioral testing while
the recent study measured BDNF expression at diﬀerent
time points after alcohol administration. It is possible
that our results reﬂect the confounding eﬀects of
cognitive testing on BDNF expression but it is highly
unlikely since all experimental groups underwent
behavioral testing. However, a more likely explanation is
that there may be diﬀerences on how BDNF expression
was assessed. That is, we analyzed the sample from
each rat and reported the data obtained as group
means while it is not clear from the recent study
whether the samples were pooled to evaluate BDNF
expression where individual variability cannot be
detected.
A critical ﬁnding in the present study is how BDNF
action directly mediates alcohol-induced depressive-like
symptoms by regulating neurogenesis. Our data
showing that depressive-like symptoms during the
alcohol withdrawal period is associated with diminished
survival and neuronal diﬀerentiation of proliferating
NPCs but enhancing BDNF signaling by giving the TrkB
agonist during alcohol consumption can restore
neurogenesis and abolish the anhedonia and despair
behavior points to this issue. It is likely that the
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inﬂuenced TrkB expression in the ETOH+ vehicle
group but not its phosphorylation because even though
no signiﬁcant diﬀerences were seen in total TrkB level,
data on phosphorylated TrkB level show diﬀerences
associated with ETOH and 7,8-DHF. The next question
that arises is what intracellular pathways may be
involved in BDNF signaling activated through the
phosphorylation of TrkB receptors that can regulate
alcohol eﬀects on neurogenesis and aﬀective behavior.
Another related question that warrants further study is
regarding other molecular mechanisms that share
common signaling pathways with BDNF that may
regulate neurogenesis and depressive-like symptoms
following chronic binge-pattern alcohol exposure.CONCLUSION
The present investigation provides possible mechanisms
that mediate the depression-like symptom seen during
the withdrawal/abstinence period following chronic binge
alcohol exposure. Our study implicates decreased
survival and neuronal diﬀerentiation of proliferating
NPCs mediated by reduced BDNF signaling in the
hippocampus as factors that may be responsible for the
predisposition to alcohol-related anhedonic and despair
behaviors during the withdrawal period. The decreased
survival of proliferating NPCs associated with alcohol
exposure as demonstrated in our data may also explain
the reduction in hippocampal volume seen in alcoholics
and those diagnosed with depression. BDNF might be
an important regulator involved in the neuroadaptation
commonly reported during alcohol withdrawal because
of its role in neural plasticity. Finally, since the common
link between decreased neurogenesis and development
of alcohol-induced depression-like symptom is BDNF as
we demonstrate in this study, it might be a molecule
that can be targeted for interventions in alcoholism–
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